Annual CFI
-$429.00 K
-$63.15 M-100.68%
31 December 2023
Summary:
Kala Pharmaceuticals annual cash flow from investing activities is currently -$429.00 thousand, with the most recent change of -$63.15 million (-100.68%) on 31 December 2023. During the last 3 years, it has risen by +$77.78 million (+99.45%). KALA annual CFI is now -100.61% below its all-time high of $70.80 million, reached on 31 December 2021.KALA Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
-$90.00 K
-$54.00 K-150.00%
30 September 2024
Summary:
Kala Pharmaceuticals quarterly cash flow from investing activities is currently -$90.00 thousand, with the most recent change of -$54.00 thousand (-150.00%) on 30 September 2024. Over the past year, it has dropped by -$9.81 million (-100.93%). KALA quarterly CFI is now -100.14% below its all-time high of $64.91 million, reached on 30 September 2022.KALA Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$146.00 K
-$9.81 M-101.51%
30 September 2024
Summary:
Kala Pharmaceuticals TTM cash flow from investing activities is currently -$146.00 thousand, with the most recent change of -$9.81 million (-101.51%) on 30 September 2024. Over the past year, it has increased by +$225.00 thousand (+60.65%). KALA TTM CFI is now -100.13% below its all-time high of $112.27 million, reached on 30 September 2021.KALA TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KALA Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -100.7% | -100.9% | +60.6% |
| 3 y3 years | +99.5% | -101.9% | -100.1% |
| 5 y5 years | +72.8% | +55.9% | +92.9% |
KALA Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -100.6% | +99.5% | -100.1% | +99.1% | -100.1% | +93.2% |
| 5 y | 5 years | -100.6% | +99.5% | -100.1% | +99.8% | -100.1% | +99.9% |
| alltime | all time | -100.6% | +99.5% | -100.1% | +99.8% | -100.1% | +99.9% |
Kala Pharmaceuticals Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$90.00 K(+150.0%) | -$146.00 K(-101.5%) |
| June 2024 | - | -$36.00 K(+176.9%) | $9.66 M(-2993.1%) |
| Mar 2024 | - | -$13.00 K(+85.7%) | -$334.00 K(-22.1%) |
| Dec 2023 | -$429.00 K(-100.7%) | -$7000.00(-100.1%) | -$429.00 K(+15.6%) |
| Sept 2023 | - | $9.72 M(-196.9%) | -$371.00 K(-100.7%) |
| June 2023 | - | -$10.03 M(+9189.8%) | $54.82 M(-19.0%) |
| Mar 2023 | - | -$108.00 K(-311.8%) | $67.68 M(+7.9%) |
| Dec 2022 | $62.72 M(-11.4%) | $51.00 K(-99.9%) | $62.72 M(+8.1%) |
| Sept 2022 | - | $64.91 M(+2195.3%) | $58.04 M(-2803.4%) |
| June 2022 | - | $2.83 M(-155.7%) | -$2.15 M(-112.1%) |
| Mar 2022 | - | -$5.07 M(+9.7%) | $17.70 M(-75.0%) |
| Dec 2021 | $70.80 M(-190.5%) | -$4.62 M(-197.9%) | $70.80 M(-36.9%) |
| Sept 2021 | - | $4.72 M(-79.2%) | $112.27 M(+124.8%) |
| June 2021 | - | $22.67 M(-52.8%) | $49.95 M(-267.1%) |
| Mar 2021 | - | $48.03 M(+30.4%) | -$29.89 M(-61.8%) |
| Dec 2020 | -$78.21 M | $36.84 M(-164.0%) | -$78.21 M(-32.1%) |
| Sept 2020 | - | -$57.60 M(+0.8%) | -$115.24 M(+99.2%) |
| June 2020 | - | -$57.16 M(>+9900.0%) | -$57.84 M(+4789.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | -$292.00 K(+55.3%) | -$1.18 M(-11.4%) |
| Dec 2019 | -$1.33 M(-15.4%) | -$188.00 K(-7.8%) | -$1.33 M(-35.1%) |
| Sept 2019 | - | -$204.00 K(-59.1%) | -$2.06 M(+3.9%) |
| June 2019 | - | -$499.00 K(+12.4%) | -$1.98 M(+20.1%) |
| Mar 2019 | - | -$444.00 K(-51.2%) | -$1.65 M(+4.5%) |
| Dec 2018 | -$1.58 M(+228.8%) | -$910.00 K(+616.5%) | -$1.58 M(+66.1%) |
| Sept 2018 | - | -$127.00 K(-24.4%) | -$950.00 K(+4.2%) |
| June 2018 | - | -$168.00 K(-55.0%) | -$912.00 K(+16.8%) |
| Mar 2018 | - | -$373.00 K(+32.3%) | -$781.00 K(+62.7%) |
| Dec 2017 | -$480.00 K(+213.7%) | -$282.00 K(+216.9%) | -$480.00 K(+87.5%) |
| Sept 2017 | - | -$89.00 K(+140.5%) | -$256.00 K(+18.5%) |
| June 2017 | - | -$37.00 K(-48.6%) | -$216.00 K(-4.0%) |
| Mar 2017 | - | -$72.00 K(+24.1%) | -$225.00 K(+47.1%) |
| Dec 2016 | -$153.00 K(-39.3%) | -$58.00 K(+18.4%) | -$153.00 K(+61.1%) |
| Sept 2016 | - | -$49.00 K(+6.5%) | -$95.00 K(+106.5%) |
| June 2016 | - | -$46.00 K(<-9900.0%) | -$46.00 K(<-9900.0%) |
| Mar 2016 | - | $0.00 | $0.00 |
| Dec 2015 | -$252.00 K | - | - |
FAQ
- What is Kala Pharmaceuticals annual cash flow from investing activities?
- What is the all time high annual CFI for Kala Pharmaceuticals?
- What is Kala Pharmaceuticals annual CFI year-on-year change?
- What is Kala Pharmaceuticals quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Kala Pharmaceuticals?
- What is Kala Pharmaceuticals quarterly CFI year-on-year change?
- What is Kala Pharmaceuticals TTM cash flow from investing activities?
- What is the all time high TTM CFI for Kala Pharmaceuticals?
- What is Kala Pharmaceuticals TTM CFI year-on-year change?
What is Kala Pharmaceuticals annual cash flow from investing activities?
The current annual CFI of KALA is -$429.00 K
What is the all time high annual CFI for Kala Pharmaceuticals?
Kala Pharmaceuticals all-time high annual cash flow from investing activities is $70.80 M
What is Kala Pharmaceuticals annual CFI year-on-year change?
Over the past year, KALA annual cash flow from investing activities has changed by -$63.15 M (-100.68%)
What is Kala Pharmaceuticals quarterly cash flow from investing activities?
The current quarterly CFI of KALA is -$90.00 K
What is the all time high quarterly CFI for Kala Pharmaceuticals?
Kala Pharmaceuticals all-time high quarterly cash flow from investing activities is $64.91 M
What is Kala Pharmaceuticals quarterly CFI year-on-year change?
Over the past year, KALA quarterly cash flow from investing activities has changed by -$9.81 M (-100.93%)
What is Kala Pharmaceuticals TTM cash flow from investing activities?
The current TTM CFI of KALA is -$146.00 K
What is the all time high TTM CFI for Kala Pharmaceuticals?
Kala Pharmaceuticals all-time high TTM cash flow from investing activities is $112.27 M
What is Kala Pharmaceuticals TTM CFI year-on-year change?
Over the past year, KALA TTM cash flow from investing activities has changed by +$225.00 K (+60.65%)